Yamani Laura Navika, Yano Yoshihiko, Utsumi Takako, Wandono Hadi, Widjanarko Doddy, Triantanoe Ari, Wasityastuti Widya, Liang Yujiao, Okada Rina, Tanahashi Toshihito, Murakami Yoshiki, Azuma Takeshi, Lusida Maria Inge, Hayashi Yoshitake
Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Indonesia-Japan Collaborative Research Centre for Emerging and Reemerging Infectious Disease, Institute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan
J Clin Microbiol. 2015 Oct;53(10):3165-75. doi: 10.1128/JCM.00602-15. Epub 2015 Jul 22.
Quasispecies of hepatitis B virus (HBV) with variations in the major hydrophilic region (MHR) of the HBV surface antigen (HBsAg) can evolve during infection, allowing HBV to evade neutralizing antibodies. These escape variants may contribute to chronic infections. In this study, we looked for MHR variants in HBV quasispecies using ultradeep sequencing and evaluated the relationship between these variants and clinical manifestations in infected patients. We enrolled 30 Indonesian patients with hepatitis B infection (11 with chronic hepatitis and 19 with advanced liver disease). The most common subgenotype/subtype of HBV was B3/adw (97%). The HBsAg titer was lower in patients with advanced liver disease than that in patients with chronic hepatitis. The MHR variants were grouped based on the percentage of the viral population affected: major, ≥20% of the total population; intermediate, 5% to <20%; and minor, 1% to <5%. The rates of MHR variation that were present in the major and intermediate viral population were significantly greater in patients with advanced liver disease than those in chronic patients. The most frequent MHR variants related to immune evasion in the major and intermediate populations were P120Q/T, T123A, P127T, Q129H/R, M133L/T, and G145R. The major population of MHR variants causing impaired of HBsAg secretion (e.g., G119R, Q129R, T140I, and G145R) was detected only in advanced liver disease patients. This is the first study to use ultradeep sequencing for the detection of MHR variants of HBV quasispecies in Indonesian patients. We found that a greater number of MHR variations was related to disease severity and reduced likelihood of HBsAg titer.
乙型肝炎病毒(HBV)准种在HBV表面抗原(HBsAg)的主要亲水区(MHR)存在变异,在感染过程中会发生进化,使HBV能够逃避中和抗体。这些逃逸变异可能导致慢性感染。在本研究中,我们使用超深度测序寻找HBV准种中的MHR变异,并评估这些变异与感染患者临床表现之间的关系。我们招募了30名印度尼西亚乙型肝炎感染患者(11名慢性肝炎患者和19名晚期肝病患者)。HBV最常见的亚基因型/亚型是B3/adw(97%)。晚期肝病患者的HBsAg滴度低于慢性肝炎患者。MHR变异根据受影响病毒群体的百分比进行分组:主要变异,占总人口的≥20%;中间变异,占5%至<20%;次要变异,占1%至<5%。晚期肝病患者中主要和中间病毒群体中存在的MHR变异率明显高于慢性患者。在主要和中间群体中,与免疫逃逸相关的最常见MHR变异是P120Q/T、T123A、P127T、Q129H/R、M133L/T和G145R。仅在晚期肝病患者中检测到导致HBsAg分泌受损的主要MHR变异群体(如G119R、Q129R、T140I和G145R)。这是第一项使用超深度测序检测印度尼西亚患者HBV准种MHR变异的研究。我们发现,更多的MHR变异与疾病严重程度相关,且HBsAg滴度降低的可能性更大。